NCT02650635 2018-09-05
TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors
Mayo Clinic
Phase 1 Terminated
Mayo Clinic
Duke University
Radiation Therapy Oncology Group
Central European Cooperative Oncology Group